Cynata Therapeutics Limited Stock Price on September 23, 2021
If you're considering investing in Cynata Pink Sheet, it is important to understand the factors that can impact its price. Cynata Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of risk over the last 3 months. By analyzing Cynata Therapeutics' technical indicators, you can evaluate if the expected return of 0.84% is justified by implied risk.
Cynata Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Cynata |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CYYNF |
Based on monthly moving average Cynata Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cynata Therapeutics by adding Cynata Therapeutics to a well-diversified portfolio.
Cynata Therapeutics Valuation on September 23, 2021
It is possible to determine the worth of Cynata Therapeutics on a given historical date. On September 23, 2021 Cynata was worth 0.3 at the beginning of the trading date compared to the closed value of 0.3. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cynata Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Cynata Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cynata Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cynata Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
04/04/2022 | 0.30 | 0.30 | 0.30 | 0.30 | 1.00 |
| 0.30 | 0.30 | 0.30 | 0.30 | 1.00 |
| Backtest Cynata Therapeutics | | | Cynata Therapeutics History | | | Cynata Therapeutics Valuation | Next |
Cynata Therapeutics Trading Date Momentum on September 23, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Cynata Therapeutics Fundamentals Correlations and Trends
By evaluating Cynata Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cynata Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cynata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cynata Therapeutics Pink Sheet history
Cynata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cynata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cynata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cynata Therapeutics stock prices may prove useful in developing a viable investing in Cynata Therapeutics
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Cynata Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Cynata Therapeutics Pink Sheet Technical Analysis
Cynata Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Cynata Therapeutics Period Price Range
Low | April 4, 2022
| High |
0.30 | 0.30 |
Cynata Therapeutics April 17, 2024 Market Strength
Market strength indicators help investors to evaluate how Cynata Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cynata Therapeutics shares will generate the highest return on investment. By undertsting and applying Cynata Therapeutics pink sheet market strength indicators, traders can identify Cynata Therapeutics Limited entry and exit signals to maximize returns
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.3 | |||
| Day Typical Price | 0.3 | |||
| Period Momentum Indicator | (0.19) | |||
| Relative Strength Index | 100.0 |
Cynata Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cynata Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cynata Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cynata to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0885 | |||
| Jensen Alpha | 1.09 | |||
| Total Risk Alpha | 0.348 | |||
| Treynor Ratio | (0.15) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cynata Therapeutics Limited. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |